Accentia trims IPO

Specialty pharma company Accentia (Tampa, Fla.) trimmed the shares and the price range of its IPO and now hopes to sell 2.5 million shares at $8-$10. A $9 deal price would raise $22.5 million and value the company at $259.9 million. The company also dropped Robert Baird from the syndicate, which still includes Jefferies; Ferris Baker Watts; Stifel Nicolaus and Gunn Allen Financial. ...